Elaine Mardis

Last updated
Elaine Mardis
Alma mater University of Oklahoma
Scientific career
Institutions McDonnell Genome Institute
Washington University in St. Louis
Bio-Rad Laboratories

Elaine R. Mardis (born September 28, 1962) is the co-executive director of the Institute for Genomic Medicine at Nationwide Children's Hospital, where she also serves as the Nationwide Foundation Endowed Chair in Genomic Medicine. [1] She also is professor of pediatrics at the Ohio State University College of Medicine. [2] Mardis’s research focuses on the genomic characterization of cancer and its implications for cancer medicine. [3] She was part of the team that reported the first next-generation-based sequencing of a whole cancer genome, [4] [5] and participated extensively in The Cancer Genome Atlas (TCGA) and the Pediatric Cancer Genome Project (PCGP). [3] [6] [7] [8]

Contents

Biography

Mardis was born in North Platte, Nebraska. She gained a passion for science at an early age, and credits her father, a chemistry professor for more than 30 years, for nurturing this passion. [9] [10]

She received her undergraduate degree in Zoology from the University of Oklahoma in 1984. [1] During her senior year she took a course in biochemistry that was taught by Bruce Roe, PhD, which says opened her eyes to the world of molecular biology. [9] She stayed at the University of Oklahoma for her doctoral studies under the supervision of Dr. Roe, who was one of the first academic scientists to have a fluorescent DNA sequencer in the laboratory. [10] As a result, during her doctoral work Mardis learned the art of DNA sequencing, at a time when few others were doing this. [9] [10]

After obtaining her PhD in chemistry and biochemistry in 1989, Mardis did postgraduate work in industry at Bio-Rad Laboratories in Hercules, California. [1]

In 1993, Mardis joined the faculty of Washington University School of Medicine. [1] Over the next 23 years, she held several and academic and leadership roles at the University, including serving as co-director of the McDonnell Genome Institute. [3] In that position, she contributed substantially to the sequencing and analysis of the human genome, [11] and was instrumental in establishing the utility of massively parallel sequencing technologies for understanding cancer biology. [3] Her work in cancer genetics and genomics has provided insights into the genetic drivers of many types of cancer, including acute myeloid leukemia, [7] [12] [13] breast cancer, [14] [15] glioblastoma, [16] and lung adenocarcinoma. [17] [18] By better defining the landscape of germline and somatic alterations, this research helps drive new strategies for treating cancer, and is central to the concept of precision medicine.

Since joining Nationwide Children's Hospital in 2016, Mardis research has incorporated next-generation sequencing assays and established knowledge about cancer genomics into clinical and therapeutic decision-making, and into the design of new approaches to cancer immunotherapy. [3] [19] [20]

In 2015, Mardis helped launch an open access, precision medicine journal, Molecular Case Studies, in conjunction with Cold Spring Harbor Laboratory Press. [21] She currently serves as Editor-in-Chief. [22] In 2020 she was Deputy Editor-in-Chief of Disease Models & Mechanisms journal, with Elizabeth Patton the Editor-in-Chief. [23] She has co-authored more than 250 articles in many prestigious publications, such as Cell, Journal of Clinical Oncology, Blood and Cancer Epidemiology, Biomarkers & Prevention. [24]

Mardis was elected as president of the American Association for Cancer Research for 2019–2020. [25]

Awards and honors

References

  1. 1 2 3 4 "Nationwide Children's Hospital: Find a Doctor" . Retrieved May 1, 2019.
  2. "The Lantern". 26 June 2018. Retrieved May 1, 2019.
  3. 1 2 3 4 5 6 "PMWC Speaker Biography". Archived from the original on February 27, 2021. Retrieved May 1, 2019.
  4. Ley, Timothy J.; Mardis, Elaine R.; Ding, Li; Fulton, Bob; McLellan, Michael D.; Chen, Ken; Dooling, David; Dunford-Shore, Brian H.; McGrath, Sean; Hickenbotham, Matthew; Cook, Lisa; Abbott, Rachel; Larson, David E.; Koboldt, Dan C.; Pohl, Craig; Smith, Scott; Hawkins, Amy; Abbott, Scott; Locke, Devin; Hillier, Ladeana W.; Miner, Tracie; Fulton, Lucinda; Magrini, Vincent; Wylie, Todd; Glasscock, Jarret; Conyers, Joshua; Sander, Nathan; Shi, Xiaoqi; Osborne, John R.; et al. (2008). "DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome". Nature . 456 (7218): 66–72. Bibcode:2008Natur.456...66L. doi:10.1038/nature07485. PMC   2603574 . PMID   18987736.
  5. Grady, Denise (November 6, 2008). ""Scientists Decode Set of Cancer Genes." New York Times, November 5, 2008". The New York Times . Retrieved May 1, 2019.
  6. "The Cancer Genome Atlas Timeline & Milestones". National Cancer Institute. 2018-06-13. Retrieved May 1, 2019.
  7. 1 2 Cancer Genome Atlas Research Network; Friedman, Allan; Bigner, Darrell; Van Meir, Erwin G.; Brat, Daniel J.; m. Mastrogianakis, Gena; Olson, Jeffrey J.; Mikkelsen, Tom; Lehman, Norman; Aldape, Ken; Alfred Yung, W. K.; Bogler, Oliver; Vandenberg, Scott; Berger, Mitchel; Prados, Michael; Muzny, Donna; Morgan, Margaret; Scherer, Steve; Sabo, Aniko; Nazareth, Lynn; Lewis, Lora; Hall, Otis; Zhu, Yiming; Ren, Yanru; Alvi, Omar; Yao, Jiqiang; Hawes, Alicia; Jhangiani, Shalini; Fowler, Gerald; et al. (2008). "Comprehensive genomic characterization defines human glioblastoma genes and core pathways". Nature. 455 (7216): 1061–1068. Bibcode:2008Natur.455.1061M. doi:10.1038/nature07385. PMC   2671642 . PMID   18772890.
  8. Zhang, J.; Wu, G.; Miller, C. P.; Tatevossian, R. G.; Dalton, J. D.; Tang, B.; Orisme, W.; Punchihewa, C.; Parker, M.; Qaddoumi, I.; Boop, F. A.; Lu, C.; Kandoth, C.; Ding, L.; Lee, R.; Huether, R.; Chen, X.; Hedlund, E.; Nagahawatte, P.; Rusch, M.; Boggs, K.; Cheng, J.; Becksfort, J.; Ma, J.; Song, G.; Li, Y.; Wei, L.; Wang, J.; Shurtleff, S.; et al. (2013). "Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas". Nature Genetics . 45 (6): 602–612. doi:10.1038/ng.2611. PMC   3727232 . PMID   23583981.
  9. 1 2 3 Mardis, E.; Dhillon, P. (2014). "Revolutionizing cancer care with next-generation sequencing: an interview with Elaine Mardis". Disease Models & Mechanisms. 7 (3): 313–317. doi:10.1242/dmm.015396. PMC   3944491 . PMID   24609032.
  10. 1 2 3 Arbanas, Caroline (September 10, 2008). "Genome technology wizard". The Source, Washington University in St. Louis . Retrieved May 1, 2019.
  11. Purddy, Michael C. (October 21, 2004). "Genome center is major contributor to 'finished' human genome sequence". Washington University in St. Louis. Retrieved May 1, 2019.
  12. Mardis, Elaine R.; Ding, Li; Dooling, David J.; Larson, David E.; McLellan, Michael D.; Chen, Ken; Koboldt, Daniel C.; Fulton, Robert S.; Delehaunty, Kim D.; McGrath, Sean D.; Fulton, Lucinda A.; Locke, Devin P.; Magrini, Vincent J.; Abbott, Rachel M.; Vickery, Tammi L.; Reed, Jerry S.; Robinson, Jody S.; Wylie, Todd; Smith, Scott M.; Carmichael, Lynn; Eldred, James M.; Harris, Christopher C.; Walker, Jason; Peck, Joshua B.; Du, Feiyu; Dukes, Adam F.; Sanderson, Gabriel E.; Brummett, Anthony M.; Clark, Eric; et al. (2009). "Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome". The New England Journal of Medicine . 361 (11): 1058–1066. doi:10.1056/NEJMoa0903840. PMC   3201812 . PMID   19657110.
  13. Ding, Li; Ley, Timothy J.; Larson, David E.; Miller, Christopher A.; Koboldt, Daniel C.; Welch, John S.; Ritchey, Julie K.; Young, Margaret A.; Lamprecht, Tamara; McLellan, Michael D.; McMichael, Joshua F.; Wallis, John W.; Lu, Charles; Shen, Dong; Harris, Christopher C.; Dooling, David J.; Fulton, Robert S.; Fulton, Lucinda L.; Chen, Ken; Schmidt, Heather; Kalicki-Veizer, Joelle; Magrini, Vincent J.; Cook, Lisa; McGrath, Sean D.; Vickery, Tammi L.; Wendl, Michael C.; Heath, Sharon; Watson, Mark A.; Link, Daniel C.; et al. (2012). "Clonal evolution in relapsed acute myeloid leukemia revealed by whole-genome sequencing". Nature. 481 (7382): 506–10. Bibcode:2012Natur.481..506D. doi:10.1038/nature10738. PMC   3267864 . PMID   22237025.
  14. Ellis, Matthew J.; Ding, Li; Shen, Dong; Luo, Jingqin; Suman, Vera J.; Wallis, John W.; Van Tine, Brian A.; Hoog, Jeremy; Goiffon, Reece J.; Goldstein, Theodore C.; Ng, Sam; Lin, Li; Crowder, Robert; Snider, Jacqueline; Ballman, Karla; Weber, Jason; Chen, Ken; Koboldt, Daniel C.; Kandoth, Cyriac; Schierding, William S.; McMichael, Joshua F.; Miller, Christopher A.; Lu, Charles; Harris, Christopher C.; McLellan, Michael D.; Wendl, Michael C.; Deschryver, Katherine; Allred, D. Craig; Esserman, Laura; et al. (2012). "Whole-genome analysis informs breast cancer response to aromatase inhibition". Nature. 486 (7403): 353–60. Bibcode:2012Natur.486..353E. doi:10.1038/nature11143. PMC   3383766 . PMID   22722193.
  15. Griffith, Obi L.; Spies, Nicholas C.; Anurag, Meenakshi; Griffith, Malachi; Luo, Jingqin; Tu, Dongsheng; Yeo, Belinda; Kunisaki, Jason; Miller, Christopher A.; Krysiak, Kilannin; Hundal, Jasreet; Ainscough, Benjamin J.; Skidmore, Zachary L.; Campbell, Katie; Kumar, Runjun; Fronick, Catrina; Cook, Lisa; Snider, Jacqueline E.; Davies, Sherri; Kavuri, Shyam M.; Chang, Eric C.; Magrini, Vincent; Larson, David E.; Fulton, Robert S.; Liu, Shuzhen; Leung, Samuel; Voduc, David; Bose, Ron; Dowsett, Mitch; et al. (2018). "The prognostic effects of somatic mutations in ER-positive breast cancer". Nature Communications . 9 (1): 3476. Bibcode:2018NatCo...9.3476G. doi:10.1038/s41467-018-05914-x. PMC   6123466 . PMID   30181556.
  16. McLendon, Roger; Friedman, Allan; Bigner, Darrell; Van Meir, Erwin G.; Brat, Daniel J.; m. Mastrogianakis, Gena; Olson, Jeffrey J.; Mikkelsen, Tom; Lehman, Norman; Aldape, Ken; Alfred Yung, W. K.; Bogler, Oliver; Vandenberg, Scott; Berger, Mitchel; Prados, Michael; Muzny, Donna; Morgan, Margaret; Scherer, Steve; Sabo, Aniko; Nazareth, Lynn; Lewis, Lora; Hall, Otis; Zhu, Yiming; Ren, Yanru; Alvi, Omar; Yao, Jiqiang; Hawes, Alicia; Jhangiani, Shalini; Fowler, Gerald; et al. (2008). "Comprehensive genomic characterization defines human glioblastoma genes and core pathways". Nature. 455 (7216): 1061–8. Bibcode:2008Natur.455.1061M. doi:10.1038/nature07385. PMC   2671642 . PMID   18772890.
  17. Ding, Li; Getz, Gad; Wheeler, David A.; Mardis, Elaine R.; McLellan, Michael D.; Cibulskis, Kristian; Sougnez, Carrie; Greulich, Heidi; Muzny, Donna M.; Morgan, Margaret B.; Fulton, Lucinda; Fulton, Robert S.; Zhang, Qunyuan; Wendl, Michael C.; Lawrence, Michael S.; Larson, David E.; Chen, Ken; Dooling, David J.; Sabo, Aniko; Hawes, Alicia C.; Shen, Hua; Jhangiani, Shalini N.; Lewis, Lora R.; Hall, Otis; Zhu, Yiming; Mathew, Tittu; Ren, Yanru; Yao, Jiqiang; Scherer, Steven E.; et al. (2008). "Somatic mutations affect key pathways in lung adenocarcinoma". Nature. 455 (7216): 1069–75. Bibcode:2008Natur.455.1069D. doi:10.1038/nature07423. PMC   2694412 . PMID   18948947.
  18. Wagner, Alex H.; Devarakonda, Siddhartha; Skidmore, Zachary L.; Krysiak, Kilannin; Ramu, Avinash; Trani, Lee; Kunisaki, Jason; Masood, Ashiq; Waqar, Saiama N.; Spies, Nicholas C.; Morgensztern, Daniel; Waligorski, Jason; Ponce, Jennifer; Fulton, Robert S.; Maggi, Leonard B.; Weber, Jason D.; Watson, Mark A.; o'Conor, Christopher J.; Ritter, Jon H.; Olsen, Rachelle R.; Cheng, Haixia; Mukhopadhyay, Anandaroop; Can, Ismail; Cessna, Melissa H.; Oliver, Trudy G.; Mardis, Elaine R.; Wilson, Richard K.; Griffith, Malachi; Griffith, Obi L.; Govindan, Ramaswamy (2018). "Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer". Nature Communications. 9 (1): 3787. Bibcode:2018NatCo...9.3787W. doi:10.1038/s41467-018-06162-9. PMC   6141466 . PMID   30224629.
  19. Johanns, Tanner M.; Miller, Christopher A.; Liu, Connor J.; Perrin, Richard J.; Bender, Diane; Kobayashi, Dale K.; Campian, Jian L.; Chicoine, Michael R.; Dacey, Ralph G.; Huang, Jiayi; Fritsch, Edward F.; Gillanders, William E.; Artyomov, Maxim N.; Mardis, Elaine R.; Schreiber, Robert D.; Dunn, Gavin P. (2019). "Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma". Oncoimmunology. 8 (4): e1561106. doi:10.1080/2162402x.2018.1561106. PMC   6422384 . PMID   30906654.
  20. "Elaine R Mardis, PhD". Ohio State University. Retrieved May 1, 2019.
  21. "Press release. Cold Spring Harbor Laboratory Press" (PDF) (Press release). Retrieved May 1, 2019.
  22. "About Cold Spring Harbor Molecular Case Studies" . Retrieved May 1, 2019.
  23. "Editor biographies | Disease Models & Mechanisms | The Company of Biologists | Disease Models & Mechanisms | The Company of Biologists". journals.biologists.com. Retrieved 2021-08-11.
  24. "Elaine Mardis, PhD | Ohio State cancer researcher". The James - OSUCCC. Retrieved 2025-01-31.
  25. "Elaine R. Mardis, PhD, Named American Association for Cancer Research President-Elect 2018-2019" (Press release). Nationwide Children's Hospital. March 21, 2012. Retrieved May 1, 2019.
  26. "Distinguished Alumni". Oklahoma University. Retrieved May 1, 2019.
  27. "The Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics". AACC. Retrieved May 1, 2019.
  28. "PMWC Speaker biography: Awards". Precision Medicine World Conference 2017 Duke. Archived from the original on March 5, 2021. Retrieved May 1, 2019.
  29. "American Association for Cancer Research Announces 2019 Class of Fellows of the AACR Academy". AACR. March 25, 2019. Retrieved May 1, 2019.